WR279,396

· U.S. Army Medical Research and Development Command

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WR279,396, covering 2021-01-07 to 2021-01-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Tolerance of WR279,396 for Old World Cutaneous Leishmaniasis [Phase 2]